Physician profile
Eric Sin
NPI 1750708749
$770.48
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $63.33 · 2021: $236 · 2022: $244 · 2023: $68.59 · 2024: $55.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Products, Lp | $178.00 | 2021 | |
| Viiv Healthcare Company | $117.17 | 2019-2022 | |
| Gilead Sciences, INC. | $92.14 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $87.63 | 2019-2023 | Zerbaxa, Dificid, Recarbrio |
| Abbvie INC. | $78.87 | 2020-2024 | Teflaro |
| Janssen Biotech, INC. | $55.56 | 2019-2021 | |
| Advanced Oxygen Therapy INC. | $49.94 | 2022 | |
| Smith+Nephew, INC. | $42.44 | 2022 | |
| Solventum Corporation | $30.02 | 2024 | Activ.A.C. |
| Tactile Systems Technology INC | $23.67 | 2023 | Entre Plus, Flexitouch Plus |
| Janssen Pharmaceuticals, INC | $15.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.